Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
Just nowEZLynx Receives Gold Stevie Award® in the 2026 American Business Awards®
Just nowGreentown Go Make 2026 with Shell and Technip Energies Announces Startup Cohort
Just now/R E P E A T -- BRP Will Present Its First Quarter Fiscal Year 2027 Results and Hold Its Annual Meeting of Shareholders/
Just nowArlo Technologies to Present at the William Blair Growth Stock Conference
1m agoHII to Participate in Bernstein’s 42nd Annual Strategic Decisions Conference on May 28
Jazz Pharmaceuticals Plc logo

Jazz Pharmaceuticals Plc

About

239.01USD+1.56 +0.66%
Closed • Updated at 13:38 GMT+00:00
Market Cap$15.00B
Volume835.3K
Beta0.19
RSI75.47
Gross Margin72.85%
Health TechnologyPharmaceuticals: Major

Jazz Pharmaceuticals Plc — investor relations, events, news, and company updates on 6ix.

Latest News

May 5 2026
Jazz Pharmaceuticals Announces First Quarter 2026 Financial Results
Apr 30 2026
ALX Oncology Announces That CD47 Biomarker Data from Clinical Trial Evaluating Evorpacept + Zanidatamab Combination in Advanced Breast Cancer Will Be Presented at ESMO Breast Cancer 2026
Apr 27 2026
Jazz Pharmaceuticals Announces FDA Acceptance and Priority Review of Supplemental Biologics License Application for Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2+ Locally Advanced or Metastatic GEA
Apr 22 2026
HealthCare Royalty Announces Royalty Monetization Agreement for Modeyso® Commercial Royalties
Apr 21 2026
Jazz Pharmaceuticals to Report First Quarter Financial Results on May 5, 2026

Community Chat

Ask AI

6ix6ixAIEvents